retatrutide who makes it Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide - Wikipedia

These medications are typically administered via a once-weekly injection

GLP-1-induced intra-islet insulin secretion may locally inhibit glucagon secretion

- Oral semaglutide (only FDA approved for diabetes treatment) and injectable liraglutide, (FDA approved for obesity treatment as Saxenda,) lead to relatively modest amount of weight loss

Individuals with a history of medullary thyroid carcinoma, MEN2, or pancreatitis are typically excluded from retatrutide trials as a class-based safety precaution

Works well for many patients, especially those new to GLP-1 therapy

If youre more holistic-minded, this might make you think: can I increase GLP-1 naturally, instead of relying on a medication to do it artificially